Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Afobazole
2. Obenoxazine
3. Aphobazole
4. Fabomotizole [inn]
5. Obenoxazine [inn]
6. Fabomotizol
7. Unii-0f8k1x115c
8. Fabomotizole (inn)
9. 0f8k1x115c
10. Cm-346
11. Fabomotizole [who-dd]
12. 5-ethoxy-2-((2-(morpholin-4-yl)ethyl)sulfanyl)-1h-benzimidazole
13. Dtxsid00169606
14. 5-ethoxy-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}-1h-1,3-benzodiazole
15. 1h-benzimidazole, 5-ethoxy-2-((2-(4-morpholinyl)ethyl)thio)-
16. Fabomotizolum
17. 5-ethoxy-2-((2-(morpholin-4-yl)ethyl)sulfanyl)-1h-1,3-benzodiazole
18. Refchem:139866
19. Dtxcid4092097
20. N05bx04
21. 173352-21-1
22. 4-(2-((5-ethoxy-1h-benzo[d]imidazol-2-yl)thio)ethyl)morpholine
23. 1h-benzimidazole, 6-ethoxy-2-[[2-(4-morpholinyl)ethyl]thio]-
24. 4-[2-[(6-ethoxy-1h-benzimidazol-2-yl)sulfanyl]ethyl]morpholine
25. Mfcd01413136
26. 4-(2-((6-ethoxy-1h-benzo[d]imidazol-2-yl)thio)ethyl)morpholine
27. 6-ethoxy-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}-1h-1,3-benzodiazole
28. Cm346
29. Fabomotizole Free Base
30. Cm346(afobazole)?
31. Fabomotizole (standard)
32. Schembl698567
33. Schembl698568
34. Orb1307299
35. Chembl3707307
36. Schembl29360845
37. Chebi:135309
38. Glxc-05973
39. Ebc-50083
40. Hy-14895r
41. Akos021631881
42. Akos032960431
43. Cs-3236
44. Db13623
45. Ncgc00390703-02
46. Ac-35218
47. Da-53102
48. Fo170131
49. Hy-14895
50. Ts-08050
51. D10561
52. 2-[2-(morpholino)ethylthio]-5-ethoxybenzimidazole
53. En300-30839366
54. Q2090655
55. Brd-k37793595-003-01-7
56. Z351640822
57. 6-ethoxy-2-{[2-(morpholin-4-yl)ethyl]sulfanyl}-1h-1,3-benzimidazole
58. 4-{2-[(6-ethoxy-1h-1,3-benzimidazol-2-yl)sulfanyl]ethyl}morpholine
| Molecular Weight | 307.4 g/mol |
|---|---|
| Molecular Formula | C15H21N3O2S |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 75.7 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 315 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BX - Other anxiolytics
N05BX04 - Fabomotizole
ATCvet Code
QN - Nervous system
QN05 - Psycholeptics
QN05B - Anxiolytics
QN05BX - Other anxiolytics
QN05BX04 - Fabomotizole
ABOUT THIS PAGE